# A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

> **NCT00293917** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 658 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Tacrolimus Cream

## Key facts

- **NCT ID:** NCT00293917
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 658 (ACTUAL)
- **Last updated:** 2008-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293917, "A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00293917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*